128 related articles for article (PubMed ID: 1640114)
1. Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration.
Merritt JA; Ball LA; Sielaff KM; Meltzer DM; Borden EC
J Interferon Res; 1992 May; Spec No():7-16. PubMed ID: 1640114
[TBL] [Abstract][Full Text] [Related]
2. Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration.
Merritt JA; Ball LA; Sielaff KM; Meltzer DM; Borden EC
J Interferon Res; 1986 Jun; 6(3):189-98. PubMed ID: 3745984
[TBL] [Abstract][Full Text] [Related]
3. 2',5'-oligoadenylate synthetase in interferon-alpha- and acyclovir-treated herpes simplex virus-infected cells.
Taylor JL; Witt PL; Irizarry A; Tom P; O'Brien WJ
J Interferon Cytokine Res; 1995 Jan; 15(1):27-30. PubMed ID: 7648430
[TBL] [Abstract][Full Text] [Related]
4. Isoforms p69 and p100 of 2',5'-oligoadenylate synthetase induced differentially by interferons in vivo and in vitro.
Witt PL; Marié I; Robert N; Irizarry A; Borden EC; Hovanessian AG
J Interferon Res; 1993 Feb; 13(1):17-23. PubMed ID: 8454907
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro induction of 2'-5' oligoadenylate synthetase by interferon-alpha in nodular non-Hodgkin's lymphoma and correlations with the clinical response.
Ferbus D; Khosravi S; Dumont J; Billard C
J Biol Regul Homeost Agents; 1990; 4(4):127-34. PubMed ID: 2096597
[TBL] [Abstract][Full Text] [Related]
6. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
[TBL] [Abstract][Full Text] [Related]
7. Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.
Pawlotsky JM; Hovanessian AG; Roudot-Thoraval F; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
Antimicrob Agents Chemother; 1996 Feb; 40(2):320-4. PubMed ID: 8834873
[TBL] [Abstract][Full Text] [Related]
8. 2-5A synthetase activity in patients with metastatic carcinoma and its response to interferon treatment.
Merritt JA; Meltzer DM; Ball LA; Borden EC
Prog Clin Biol Res; 1985; 202():423-30. PubMed ID: 3832076
[TBL] [Abstract][Full Text] [Related]
9. Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha.
Merritt JA; Borden EC; Ball LA
J Interferon Res; 1985; 5(1):191-8. PubMed ID: 3989336
[TBL] [Abstract][Full Text] [Related]
10. 2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.
Millar BC; Bell JB
Br J Cancer; 1995 Dec; 72(6):1525-30. PubMed ID: 8519671
[TBL] [Abstract][Full Text] [Related]
11. Protein synthesis-dependent and -independent induction of p69 2'-5'-oligoadenylate synthetase by interferon-alpha.
Yu F; Floyd-Smith G
Cytokine; 1999 Oct; 11(10):744-50. PubMed ID: 10525312
[TBL] [Abstract][Full Text] [Related]
12. Induction of 2',5'-oligoadenylate synthetase by retinoic acid in two transformed human cell lines.
Bourgeade MF; Besançon F
Cancer Res; 1984 Nov; 44(11):5355-60. PubMed ID: 6435868
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C is required for induction of 2',5'-oligoadenylate synthetases.
Yu F; Floyd-Smith G
Exp Cell Res; 1997 Aug; 234(2):240-8. PubMed ID: 9260891
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic study of a human recombinant interferon (Re-IFN-alpha A) in cynomolgus monkeys by 2'-5' oligoadenylate synthetase assay.
Bannai H; Tatsumi M; Kohase M; Onishi E; Yamazaki S
Jpn J Med Sci Biol; 1985 Jun; 38(3):113-24. PubMed ID: 2999483
[TBL] [Abstract][Full Text] [Related]
15. Effects of human gamma interferon on cell growth, replication of virus and induction of 2'-5'oligoadenylate synthetase in three human lymphoblastoid cell lines and K562 cells.
Tomita Y; Cantell K; Kuwata T
Int J Cancer; 1982 Aug; 30(2):161-5. PubMed ID: 6182110
[TBL] [Abstract][Full Text] [Related]
16. Functional differences in the promoters of the interferon-inducible (2'-5')A oligoadenylate synthetase and 6-16 genes in interferon-resistant Daudi cells.
Guille MJ; Laxton CD; Rutherford MN; Williams BR; Kerr IM
Eur J Biochem; 1994 Jan; 219(1-2):547-53. PubMed ID: 8307020
[TBL] [Abstract][Full Text] [Related]
17. Minimal dose of aerosolized interferon-alpha in human subjects: biological consequences and side-effects.
Giosuè S; Casarini M; Ameglio F; Alemanno L; Saltini C; Bisetti A
Eur Respir J; 1996 Jan; 9(1):42-6. PubMed ID: 8834332
[TBL] [Abstract][Full Text] [Related]
18. Basal and interferon-induced 2',5'-oligoadenylate synthetase activity in human placental trophoblast and trophoblast-derived malignant cell lines.
Dalsgaard AM; Aboagye-Mathiesen G; Justesen J; Zdravkovic M; Ebbesen P
Placenta; 1995 Mar; 16(2):137-46. PubMed ID: 7540757
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of HuIFN-gamma on 2',5'-oligoadenylate synthetase induction by HuIFN-alpha.
Justesen J; Berg K
J Interferon Res; 1986 Aug; 6(4):445-54. PubMed ID: 3095443
[TBL] [Abstract][Full Text] [Related]
20. Induction of 2',5'-oligoadenylate synthetase in freshly separated malignant cells from solid tumors. Variability in the susceptibility of interferon.
Einhorn S; Vánky F; Grandér D; Willems JS
Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1607-13. PubMed ID: 2448144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
